The 90+-year-old female patient presented to the Trinmo Rybay Bethmorgreene Burgstern Medical University Of Medical Center Department on 5/1/06 with an intermittently cold and blue right foot, and gangrene was noticed in the second and third right lower extremity toes. She had significant medical issues such as dementia, coronary artery disease, diabetes, and PVOD. She underwent and tolerated a right AKA on 7/8/06 without any complications, and after recovery from anesthesia was admitted to the general care floor. Her diet was advanced as tolerated and the pain was well controlled with oral pain medications and she was evaluated by physical therapy. She was treated with perioperative ancef and switched to one week of p.o. linezolid just prior to discharge. At the time of discharge, the patient was afebrile, vital signs stable, with the right AKA stump well healed and with mild erythema inferior to the incision. Her discharge medications included Trazodone 50 mg nightly, Celexa 20 mg daily, Colace 100 mg b.i.d., Hydrochlorothiazide 25 mg daily, Novolog sliding scale, Lantus 20 units subcutaneously q.a.m., FiberCon one tablet, MVI daily, Synthroid 25 mcg daily, Linezolid 600 mg p.o. q.12h. x10 doses starting today, Zyprexa 2.5 mg p.o. q.p.m., and Tylenol Elixir 1000 mg p.o. q.6h. p.r.n. pain and Lactulose 30 mL p.o. daily p.r.n. constipation. She was discharged to her skilled nursing facility with plans to follow up with her primary care physician and Dr. Wynder in one to two weeks. The patient is DNR/DNI.
Is the patient currently or have they ever taken fibercon
FiberCon one tablet,